- TheStreet.com•13 hours ago
Also up early Thursday: Bellicum and Novocure.
- Reuters•15 hours ago
Cyclacel Pharmaceuticals Inc said its lead experimental drug did not help elderly patients with acute myeloid leukemia live longer in a late-stage study. The drug developer's stock was down about 19 percent ...
- MarketWatch•15 hours ago
Shares of Cyclacel Pharmaceuticals Inc. plunged 19% in premarket trade Thursday, after disappointing late-stage trial results of its leukemia treatment. The company said a phase 3 Seamless trial of its ...
CYCC : Summary for Cyclacel Pharmaceuticals, Inc. - Yahoo Finance
Cyclacel Pharmaceuticals, Inc. (CYCC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.01 x 500|
|Ask||4.38 x 500|
|Day's Range||3.80 - 4.69|
|52 Week Range||3.05 - 9.72|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.97|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|